相关实验视频
Updated: May 25, 2025
05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
77
使用血p217+tau进行阿尔茨海默病生物PET分期
Azadeh Feizpour1,2, Vincent Doré2,3, Natasha Krishnadas1,2
1Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
Communications medicine
|February 27, 2025
概括
血p217+tau精确选阿尔茨海默病 (AD) 并识别中级/高级AD阶段. 这种生物标志物可以减少在高级AD诊断中需要tau PET成像的需要.
科学领域:
- 神经学 神经学
- 生物标志物发现发现
- 阿尔茨海默氏症疾病研究研究
背景情况:
- 像p217+tau这样的等离子体酸生物标志物在检测阿尔茨海默氏病 (AD) 神经病理学方面是有效的.
- 血生物标志物的实用性,以取代TAU PET来确定AD的生物分期,仍在调查中.
研究的目的:
- 评估血p217+tau在识别和分期阿尔茨海默病 (AD) 生物进展中的疗效.
- 将血p217+tau的诊断性能与已建立的Aβ-PET和tau-PET成像标准进行比较.
主要方法:
- 利用了来自248名认知不受损和227名认知受损个体的血p217+tau,Aβ-PET和tau-PET数据.
- 根据阿尔茨海默病诊断和分期的修订标准 (2024) 定义了阿尔茨海默病的生物阶段 (初始,早期,中期,高级).
- 通过ROC分析和后勤回归来评估血p217+tau在区分AD阶段的性能.
主要成果:
- 血p217+tau度与AD生物学PET阶段相关.
- 观察到高诊断准确度 (AUC > 0.90) 选所有AD阶段和识别组合的中间/高级阶段.
- 血p217+tau在中级/高级AD阶段表现出良好的灵敏度和特异性,在高级阶段具有高的NPV.
结论:
- 血p217+tau有效地选了粉样蛋白阳性 (A+) 个体.
- 血p217+tau可以识别结合中级/高级AD阶段的个体.
- 这种生物标志物可以作为预查工具,以优化TAU-PET成像的使用,以识别高级阶段AD的个体.
相关概念视频
01:29Positron Emission Tomography
4.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
65
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
65